| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T1 |
0-56 |
Sentence |
denotes |
Systemic Inflammation in Preclinical Ulcerative Colitis. |
| T2 |
57-75 |
Sentence |
denotes |
BACKGROUND & AIMS: |
| T3 |
76-125 |
Sentence |
denotes |
Preclinical ulcerative colitis is poorly defined. |
| T4 |
126-250 |
Sentence |
denotes |
We aimed to characterize the preclinical systemic inflammation in ulcerative colitis, using a comprehensive set of proteins. |
| T5 |
251-259 |
Sentence |
denotes |
METHODS: |
| T6 |
260-452 |
Sentence |
denotes |
We obtained plasma samples biobanked from individuals who developed ulcerative colitis later in life (n = 72) and matched healthy controls (n = 140) within a population-based screening cohort. |
| T7 |
453-535 |
Sentence |
denotes |
We measured 92 proteins related to inflammation using a proximity extension assay. |
| T8 |
536-690 |
Sentence |
denotes |
The biologic relevance of these findings was validated in an inception cohort of patients with ulcerative colitis (n = 101) and healthy controls (n = 50). |
| T9 |
691-902 |
Sentence |
denotes |
To examine the influence of genetic and environmental factors on these markers, a cohort of healthy twin siblings of patients with ulcerative colitis (n = 41) and matched healthy controls (n = 37) were explored. |
| T10 |
903-911 |
Sentence |
denotes |
RESULTS: |
| T11 |
912-1108 |
Sentence |
denotes |
Six proteins (MMP10, CXCL9, CCL11, SLAMF1, CXCL11 and MCP-1) were up-regulated (P < .05) in preclinical ulcerative colitis compared with controls based on both univariate and multivariable models. |
| T12 |
1109-1314 |
Sentence |
denotes |
Ingenuity Pathway Analyses identified several potential key regulators, including interleukin-1β, tumor necrosis factor, interferon-gamma, oncostatin M, nuclear factor-κB, interleukin-6, and interleukin-4. |
| T13 |
1315-1405 |
Sentence |
denotes |
For validation, we built a multivariable model to predict disease in the inception cohort. |
| T14 |
1406-1559 |
Sentence |
denotes |
The model discriminated treatment-naïve patients with ulcerative colitis from controls with leave-one-out cross-validation (area under the curve = 0.92). |
| T15 |
1560-1781 |
Sentence |
denotes |
Consistently, MMP10, CXCL9, CXCL11, and MCP-1, but not CCL11 and SLAMF1, were significantly up-regulated among the healthy twin siblings, even though their relative abundances seemed higher in incident ulcerative colitis. |
| T16 |
1782-1794 |
Sentence |
denotes |
CONCLUSIONS: |
| T17 |
1795-1898 |
Sentence |
denotes |
A set of inflammatory proteins are up-regulated several years before a diagnosis of ulcerative colitis. |
| T18 |
1899-2070 |
Sentence |
denotes |
These proteins were highly predictive of an ulcerative colitis diagnosis, and some seemed to be up-regulated already at exposure to genetic and environmental risk factors. |
| T1 |
0-56 |
Sentence |
denotes |
Systemic Inflammation in Preclinical Ulcerative Colitis. |
| T2 |
57-75 |
Sentence |
denotes |
BACKGROUND & AIMS: |
| T3 |
76-125 |
Sentence |
denotes |
Preclinical ulcerative colitis is poorly defined. |
| T4 |
126-250 |
Sentence |
denotes |
We aimed to characterize the preclinical systemic inflammation in ulcerative colitis, using a comprehensive set of proteins. |
| T5 |
251-259 |
Sentence |
denotes |
METHODS: |
| T6 |
260-452 |
Sentence |
denotes |
We obtained plasma samples biobanked from individuals who developed ulcerative colitis later in life (n = 72) and matched healthy controls (n = 140) within a population-based screening cohort. |
| T7 |
453-535 |
Sentence |
denotes |
We measured 92 proteins related to inflammation using a proximity extension assay. |
| T8 |
536-690 |
Sentence |
denotes |
The biologic relevance of these findings was validated in an inception cohort of patients with ulcerative colitis (n = 101) and healthy controls (n = 50). |
| T9 |
691-902 |
Sentence |
denotes |
To examine the influence of genetic and environmental factors on these markers, a cohort of healthy twin siblings of patients with ulcerative colitis (n = 41) and matched healthy controls (n = 37) were explored. |
| T10 |
903-911 |
Sentence |
denotes |
RESULTS: |
| T11 |
912-1108 |
Sentence |
denotes |
Six proteins (MMP10, CXCL9, CCL11, SLAMF1, CXCL11 and MCP-1) were up-regulated (P < .05) in preclinical ulcerative colitis compared with controls based on both univariate and multivariable models. |
| T12 |
1109-1314 |
Sentence |
denotes |
Ingenuity Pathway Analyses identified several potential key regulators, including interleukin-1β, tumor necrosis factor, interferon-gamma, oncostatin M, nuclear factor-κB, interleukin-6, and interleukin-4. |
| T13 |
1315-1405 |
Sentence |
denotes |
For validation, we built a multivariable model to predict disease in the inception cohort. |
| T14 |
1406-1559 |
Sentence |
denotes |
The model discriminated treatment-naïve patients with ulcerative colitis from controls with leave-one-out cross-validation (area under the curve = 0.92). |
| T15 |
1560-1781 |
Sentence |
denotes |
Consistently, MMP10, CXCL9, CXCL11, and MCP-1, but not CCL11 and SLAMF1, were significantly up-regulated among the healthy twin siblings, even though their relative abundances seemed higher in incident ulcerative colitis. |
| T16 |
1782-1794 |
Sentence |
denotes |
CONCLUSIONS: |
| T17 |
1795-1898 |
Sentence |
denotes |
A set of inflammatory proteins are up-regulated several years before a diagnosis of ulcerative colitis. |
| T18 |
1899-2070 |
Sentence |
denotes |
These proteins were highly predictive of an ulcerative colitis diagnosis, and some seemed to be up-regulated already at exposure to genetic and environmental risk factors. |